Arch Biopartners Announces Start of GMP Manufacturing for AB569 at Dalton Pharma Services
TORONTO, ONTARIO–(Marketwired – May 4, 2017) – Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE:ARCH)(OTCBB:ACHFF) a portfolio-based biotechnology company, […]